相关实验视频
Updated: Jul 6, 2026

08:58
Artificial Intelligence Approaches to Assessing Primary Cilia
Published on: May 1, 2021
3.4K
单细胞阵列增强细胞损伤识别使用人工智能用于抗癌药物发现
Qingxuan Li1, Jiangshan Zhou1, Songyao Jiang2
1Department of Chemical Engineering, Northeastern University, Boston, Massachusetts 02115, United States.
Analytical chemistry
|February 10, 2025
概括
这项研究介绍了一种使用单细胞阵列来准确识别癌细胞损伤的AI驱动的方法. 该方法有效评估药物毒性,并有助于选潜在的抗癌药物.
科学领域:
- 生物技术是生物技术.
- 人工智能的人工智能
- 癌症研究 癌症研究
背景情况:
- 准确评估药物诱导的细胞损伤对于癌症治疗和药物开发至关重要.
- 传统方法经常面临细胞细分,背景噪音和计算效率等挑战.
- 开发高通量,准确的监测细胞健康的方法对于个性化医学至关重要.
研究的目的:
- 开发和验证一种基于人工智能 (AI) 的方法,用于使用单细胞阵列识别细胞损伤.
- 提高潜在抗癌药物的毒性评估的准确性和效率.
- 为了能够精确地分类癌细胞状态和损伤水平.
主要方法:
- 利用单细胞微模式 (micropatches和microwells) 来隔离单个细胞,最大限度地减少重叠并保留细胞轮.
- 采用光显微镜来监测细胞的形态和反应性氧物种强度的变化暴露于治疗药物,如多克索鲁比辛.
- 训练了一个卷积神经网络 (CNN) 模型,使用不同度药物暴露前后的癌细胞时间序列图像.
主要成果:
- 人工智能模型准确地识别了癌细胞状态 (活/死),并分类了损伤水平 (严重/中度/轻微).
- 单细胞阵列方法消除了对计算细胞细分的需求,减少了背景噪声和干扰.
- 提高图像识别的准确性和加速计算分析,用于毒性预测.
结论:
- 开发的单细胞阵列方法与人工智能相结合,为细胞损伤识别提供了一个高度准确和高效的平台.
- 这种人工智能驱动的方法加快了毒性分析,促进了潜在抗癌药物的查.
- 该方法对推进癌症研究和药物发现管道有前途.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

